Spanish Red Biotech Pipeline

Gilead Sciences

Simtuzumab

Type: Biodrugs/ Drugs
Therapeutic area: Respiratory and Pulmonary system
Indication: Idiopathic pulmonary fibrosis
Phase: 2Phase II in Spain, 1Phase I